Company news

Quanterix Corporation news in 2021

Quanterix Corporation's news releases, calls and decks from 2021, newest first.

View company

Quanterix Corporation Releases Operating Results for Third Quarter of 2021

November 3, 2021

Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021

October 27, 2021

Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease

October 10, 2021

Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test

September 12, 2021

Quanterix Corporation Releases Operating Results for Second Quarter of 2021

August 4, 2021

Quanterix Appoints Michael Doyle as Chief Financial Officer

June 27, 2021

Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics

May 10, 2021

Quanterix Corporation Releases Operating Results for First Quarter 2021

May 4, 2021

Quanterix Appoints Laurie Olson to Board of Directors

April 27, 2021

Quanterix Announces Appointment of Interim Chief Financial Officer

April 20, 2021

Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020

March 1, 2021

Quanterix Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021

February 22, 2021

Quanterix Announces Simoa® Joint Laboratory with WuXi AppTec

February 11, 2021

Quanterix Announces Closing of Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares

February 7, 2021

Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock

February 2, 2021

Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test

January 10, 2021

Calls in 2021

Decks in 2021